The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,814.00
Bid: 1,813.00
Ask: 1,814.00
Change: 4.00 (0.22%)
Spread: 1.00 (0.055%)
Open: 1,811.00
High: 1,814.50
Low: 1,810.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Shares Mixed As Pound Falls To Near USD1.30

Tue, 05th Jul 2016 16:01

LONDON (Alliance News) - London stocks ended mixed Tuesday, with the FTSE 100 index of large international companies back on track after giving back gains on Monday, but with the pound and more UK-exposed measures of stock performance continuing to decline.

Blue-chips were boosted by the Bank of England's announcement of a series of measures to stabilize in the UK financial system following the vote to leave the European Union.

The central bank, in its twice-yearly Financial Stability Report, unveiled moves to help boost lending, as it warned of a "challenging" outlook for financial stability after the Brexit vote. The bank slashed funding rules for banks as part of measures to shore up the economy and financial system and said it "stands ready to take any further actions" if needed.

"There will be a period of uncertainty and adjustment following the result of the referendum. It will take time for the UK to establish new relationships with the EU and the rest of the world," said the report.

The BoE added that, despite a severe hit to the pound and declines of as much as 20% for bank shares since the vote, the UK banking sector has proved resilient, with little sign so far of a credit squeeze.

The Bank of England will reduce the capital required to be held on banks' balance sheets by GBP5.7 billion, which it said would help bolster their ability to lend to households and businesses by up to GBP150 billion. The so-called countercyclical capital buffer rate has been slashed to zero from 0.5% and will remain at that level for at least a year, the central bank said.

However, Ben Brettell, senior economist at Hargreaves Lansdown, said it is worth remembering that lending volumes depend on demand as well as supply.

"If already indebted households become more risk averse following the referendum, the demand for credit simply won't be there, however much the banks are willing to lend," Brettell noted.

The BoE announcement came after Governor Mark Carney said last week that policymakers were preparing to ease monetary policy over the summer, with analysts saying that a cut to UK interest rates could arrive either at the Monetary Policy Committee meeting of July 14 or at the next meeting on August 4.

The pound stood at a new 31-year low of USD1.3035 at the London equities close Tuesday, having been at USD1.3324 at the same time Monday.

Equity investors responded to the BoE measures by sending large-cap stocks higher, with the FTSE 100 ending up 0.4%, or 27.20 points, at 6,549.46. The index had started the session lower, adding to losses from Monday, when it had ended its post-Brexit winning streak at four sessions.

However, the more domestically exposed FTSE 250 index fell 2.7%, or 428.92 points, at 15,687.78. The AIM All-Share declined 1.0%, or 6.76 points, at 707.10.

The UK service sector activity growth weakened to match the 38-month low registered in April, survey results from Markit showed. The Markit/Chartered Institute of Procurement & Supply services Purchasing Managers' Index dropped to 52.3 in June from 53.5 in May, below expectations of a reading of 52.8. Nevertheless, a reading above 50.0 signals growth in the sector.

"The majority of respondents completed the survey before Brexit and attributed these effects to both a general slowing in the UK economy and a pause in normal economic activity as customers and business awaited the results of the EU referendum," said David Noble, chief executive officer at CIPS.

This came a day after the UK construction PMI reading from Markit and CIPS fell to 46.0 in June, representing shrinkage, from 51.2 in May against economists' expectations of a drop to 50.5.

Germany's services sector weakened at the end of the second quarter. The final services PMI dropped to a 13-month low of 53.7 in June from 55.2 in May. Nonetheless, the reading was above the flash score of 53.2. Meanwhile, the same from France declined to 49.9, in line with the flash estimate, from 51.6 in May.

Eurozone retail sales increased for the second straight month in May, figures from Eurostat showed. Retail sales climbed 0.4% month-on-month in May, following a 0.2% rise in April. On a yearly basis, retail sales growth accelerated to 1.6% in May from 1.4% in April. That was below economists' expectations for a 1.7% gain, however.

The CAC 40 index in Paris fell 1.7% and the DAX 30 in Frankfurt lost 1.8%. The euro was quoted at USD1.1094 at the equities close, compared to USD1.1144 late Monday.

Stocks in New York were firmly in the red at the London close, with the Dow 30 down 0.6%, the S&P 500 down 0.8% and the Nasdaq Composite down 1.0%. New orders for US manufactured goods pulled back in line with estimates in May, a report from the US Commerce Department showed.

The Commerce Department said factory orders fell by 1.0% in May following a 1.8% increase in April. The drop in orders matched economist estimates. The decline in factory orders was primarily due to a sharp pullback in durable goods orders, which tumbled by 2.3% in May after surging up by 3.2% in April.

Gold stood at USD1,349.32 an ounce late Tuesday in London, against USD1,351.08 on Monday, while Brent oil fell below the USD50 line, quoted at USD47.89 a barrel, compared to USD50.15 on Monday.

On the London Stock Exchange, Royal Dutch Shell 'A' shares and BP ended among the best blue-chip performers, up 2.6% and 1.5%, respectively, after Barclays lifted its price targets on both oil producers. Meanwhile, tobacco giants British American Tobacco, up 2.7%, and Imperial Brands, up 0.9%, also benefited from price-target upgrades by Goldman Sachs.

International Consolidates Airlines Group ended up 0.9%, taking back some of its losses from Monday after an investigation was launched in Spain into IAG's low-cost airline Vueling following chaos at Barcelona airport over the weekend.

IAG, which also owns British Airways, Ireland's Aer Lingus, and Spain's Iberia, said Tuesday its group traffic measured by revenue passenger kilometres rose 14% in June on a year before. Group capacity measured in available seat kilometres rose 13%, while load factor improved as a result to 84.0% from 83.7%.

On a pro-forma basis, taking into account the acquisition last year of Irish flag carrier Aer Lingus, traffic rose 3.5%, whilst capacity rose 3.3%. Group premium traffic rose 0.1% in May on a year before, also on a pro-forma basis.

Also gaining were GlaxoSmithKline, up 2.8%, and Hikma Pharmaceuticals, up 2.2%, as well as National Grid, up 2.3% and United Utilities Group, up 1.0%.

"With UK property funds in turmoil and looking vulnerable to further falls, the list of 'safe haven' dividend payers has got shorter, and this helps to explain why stalwart firms like utilities and pharmaceuticals are in the ascendant," said IG senior market analyst Chris Beauchamp.

Real estate investors ended amongst the worst performing stocks again after downgrades by French bank Societe Generale. Land Securities Group fell 3.7% after SocGen cut its recommendation on the stock to Hold from Buy, British Land dropped 2.6%, having received the same downgrade.

SocGen said the UK exit from the European Union comes at a time when the property cycle was reversing anyway due to fast-rising speculative supply. While the outcome of this is difficult to predict, SocGen forecasts property prices to fall 25% peak-to-trough.

Persimmon shares fell 5.4%. The housebuilder sounded a note of caution about the uncertainty caused by the Brexit vote for the UK's new homes market, despite reporting higher house sales at higher prices for the first half. Other housebuilders also closed in the red due to the Brexit-related cloud of uncertainty over the sector, with Barratt Developments down 5.4% and Berkeley Group Holdings down 6.4%.

Insurers suffered as well, with Legal & General down 6.8% and Standard Life down 4.3%. Standard Life Investments, the investment management arm of Standard Life, suspended trading in Standard Life Investments UK Real Estate Fund, saying it wanted to "protect the interests of all investors" as a high number of investors attempted to withdraw their funds following the Brexit vote.

In the UK corporate calendar, easyJet releases June traffic statistics, and Low & Bonar publishes half-year results. Carillion, Topps Tiles and Booker Group release trading statements.

Economic calendar highlights for Wednesday are German factory orders at 0700 BST, the US Redbook index at 1355 BST, and US Markit services and composite PMI readings at 1445 BST.

At 1900 BST, the result of the first round of the Conservative Party leadership selection process is expected.

After the London equities close on Wednesday, the US Federal Reserve will release the minutes of its last monetary policy meeting at 1900 BST.

By Daniel Ruiz; danielruiz@alliancenews.com

Copyright 2016 Alliance News Limited. All Rights Reserved.

More News
1 May 2024 08:50

TOP NEWS: GSK expects momentum to continue after strong first quarter

(Alliance News) - GSK PLC on Wednesday raised its annual earnings forecast, and said it expects sales growth at the top-end of guidance, after a "strong" start to the year.

Read more
1 May 2024 07:46

LONDON BRIEFING: GSK ups outlook; Next first-quarter beats forecast

(Alliance News) - Equities in London are called to open flat on Wednesday, ahead of the latest Federal Reserve interest rate decision, while a host of financial markets in mainland Europe and beyond are closed for public holidays.

Read more
1 May 2024 07:36

GSK lifts annual guidance on strong virus treatment sales

(Sharecast News) - UK pharmaceutical giant GSK lifted annual profits guidance on Wednesday, as it pinned its hopes on demand for its respiratory virus and shingles treatments.

Read more
30 Apr 2024 23:46

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 22:39

First trial over Zantac cancer claims set to begin in Chicago

April 30 (Reuters) - The first trial over claims that blockbuster heartburn drug Zantac, once sold by GSK and other companies, causes cancer is set to begin this week in Chicago.

Read more
30 Apr 2024 13:51

Sensodyne maker Haleon to shut UK factory with loss of 435 jobs

(Alliance News) - More than 400 jobs are to be axed at Sensodyne toothpaste and Advil painkillers firm Haleon PLC as the group revealed plans to shut its only manufacturing site in the UK.

Read more
30 Apr 2024 12:22

Sensodyne-maker Haleon to shut UK plant, 435 jobs to go

April 30 (Reuters) - Haleon, the world's largest standalone consumer healthcare firm, will shut its UK production site which makes Sensodyne toothpastes by 2026, leading to 435 job losses, a spokesperson said on Tuesday.

Read more
25 Apr 2024 15:53

GlaxoSmithKline sues Pfizer and BioNTech over Covid-19 vaccine technology

April 25 (Reuters) - GlaxoSmithKline sued Pfizer and BioNTech in Delaware federal court on Thursday, accusing them of infringing GSK patents related to messenger RNA (mRNA) technology in the companies' blockbuster COVID-19 vaccines.

Read more
24 Apr 2024 14:19

UK earnings, trading statements calendar - next 7 days

Thursday 25 April 
Aquila European Renewables PLCFull Year Results
Argo Blockchain PLCFull Year Results
AstraZeneca PLCQ1 Results
Barclays PLCQ1 Results
Checkit PLCFull Year Results
Coca-Cola Europacific Partners PLCTrading Statement
Destiny Pharma PLCFull Year Results
Dillistone Group PLCFull Year Results
Focusrite PLCHalf Year Results
Gem Diamonds LtdTrading Statement
Hikma Pharmaceuticals PLCTrading Statement
Hummingbird Resources PLCTrading Statement
Ibstock PLCTrading Statement
Inchcape PLCTrading Statement
J Sainsbury PLCFull Year Results
London Stock Exchange Group PLCQ1 Results
Persimmon PLCTrading Statement
Pinewood Technologies Group PLCFull Year Results
PPHE Hotel Group LtdTrading Statement
PureTech Health PLCFull Year Results
Relx PLCTrading Statement
Renewi PLCTrading Statement
Schroders PLCQ1 Results
Skillcast Group PLCFull Year Results
Travis Perkins PLCTrading Statement
Trifast PLCTrading Statement
Unilever PLCQ1 Results
WAG Payment Solutions PLCTrading Statement
Weir Group PLCTrading Statement
WH Smith PLCHalf Year Results
WPP PLCTrading Statement
Zinc Media Group PLCFull Year Results
Friday 26 April 
Facilities by ADF PLCFull Year Results
Kingspan Group PLCTrading Statement
Loungers PLCTrading Statement
NatWest Group PLC Q1 Results
Pearson PLCTrading Statement
Record PLCTrading Statement
Smurfit Kappa Group PLCTrading Statement
Taylor Maritime Investments LtdTrading Statement
Monday 29 April 
Beazley PLCTrading Statement
Biome Technologies PLCFull Year Results
Christie Group PLCFull Year Results
Gresham House Energy Storage Fund PLCFull Year Results
Gresham Technologies PLCFull Year Results
Jadestone Energy PLCFull Year Results
Oxford BioMedica PLCFull Year Results
SpaceandPeople PLCFull Year Results
Tuesday 30 April 
Avacta Group PLCFull Year Results
Card Factory PLCFull Year Results
Capital & Regional PLCFull Year Results
Close Brothers Group PLCTrading Statement
Coca-Cola HBC AGTrading Statement
Elementis PLCTrading Statement
essensys PLCHalf Year Results
Fadel Partners IncFull Year Results
Glencore PLCTrading Statement
Hargreaves Lansdown PLC Trading Statement
Howden Joinery PLCTrading Statement
HSBC Holdings PLCQ1 Results
Kelso Group PLCFull Year Results
Northcoders Group PLCFull Year Results
Phoenix Spree Deutschland LtdFull Year Results
RBG Holdings PLCFull Year Results
Rotork PLCTrading Statement
Safestore Holdings PLCHalf Year Results
Shield Therapeutics PLCFull Year Results
St James's Place PLCTrading Statement
Strip Tinning Holdings PLCFull Year Results
Whitbread PLCFull Year Results
Wednesday 1 May 
Computacenter PLCTrading Statement
GSK PLCQ1 Results
Haleon PLCTrading Statement
HSS Hire Group PLCFull Year Results
Intelligent Ultrasound Group PLCFull Year Results
Maintel Holdings PLCFull Year Results
Next PLCTrading Statement
Smith & Nephew PLCTrading Statement
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
24 Apr 2024 09:21

GSK's endometrial cancer drug receives FDA approval

(Sharecast News) - Drugmaker GSK said on Wednesday that the US Food and Drug Administration has accepted a supplemental Biologics License Application for Jemperli, its drug aimed at treating endometrial cancer.

Read more
24 Apr 2024 09:14

GSK's Jemperli with chemotherapy accepted for priority review by FDA

(Alliance News) - GSK PLC on Wednesday said that the US Food & Drug Administration has accepted a supplemental biologics licence application for Jemperli, when used in combination with chemotherapy.

Read more
17 Apr 2024 08:46

TOP NEWS: GSK hails data on Shingles vaccine and gonorrhoea treatment

(Alliance News) - GSK PLC on Wednesday reported new test data for its shingles vaccine and for a potential new oral treatment for a form of gonorrhoea.

Read more
17 Apr 2024 07:11

GSK posts promising results from gonorrhoea treatment trial

(Sharecast News) - GSK unveiled encouraging outcomes from a pivotal phase three trial on Wednesday, on the potential of gepotidacin as an oral treatment for uncomplicated urogenital gonorrhoea (GC), amid escalating resistance to current therapies.

Read more
16 Apr 2024 09:17

GSK meningococcal vaccine accepted by US FDA for review

(Sharecast News) - GSK announced on Tuesday that its five-in-one meningococcal ABCWY (MenABCWY) vaccine candidate had been accepted for regulatory review by the US Food and Drug Administration (FDA).

Read more
16 Apr 2024 08:59

GSK's latest meningitis vaccine accepted for review by US regulator

(Alliance News) - GSK PLC on Tuesday said it has made progress in the development of its newest candidate, which combines the strengths of two other vaccines in its portfolio into one bacteria-fighting inoculation.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.